Mitchell N. Davis

6.2k citations
35 papers · 4.7k · 4 hit papers · h-index 18

Impact in

  • Hepatology top 0.1%
    • Hepatitis C virus research
    • Liver physiology and pathology
    • Liver Disease and Transplantation
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

Mitchell N. Davis

35 papers receiving 4.5k citations

Mitchell N. Davis's Hit Papers

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials 2020 · 414 citations
4140+5+11Years since publication5001k1.5k

Peers

Mitchell N. Davis
Comparison fields: 5 of 88
  • Hepatology 4k
  • Epidemiology 425
  • Family Practice 11
  • Biological Psychiatry 5
  • Infectious Diseases 67
Replace Lisa M. Nyberg with:
Lisa M. Nyberg United States
Kathryn Razavi‐Shearer United States
Jonathan McCone United States
Jan Šperl Czechia
Jian Hui Yu China
Andrew J. Muir United States
John J. Mcnally United States
Sarah Arterburn United States
Fernando Lopes Gonçales Brazil
Aasim M. Sheikh United States
Mitchell N. Davis relative to Lisa M. Nyberg United States Lisa M. Nyberg's profile →
Citations per field
00.5×2×4×6×8.5×
Lisa M. Nyberg · 1×
Citations per year

Countries citing papers authored by Mitchell N. Davis

Since Specialization
Citations

This map shows the geographic impact of Mitchell N. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell N. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell N. Davis more than expected).

Fields of papers citing papers by Mitchell N. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell N. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell N. Davis. The network helps show where Mitchell N. Davis may publish in the future.

Co-authors

The 25 scholars most cited alongside Mitchell N. Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mitchell N. Davis Line = papers co-authored together Mitchell N. Davis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Hit paper breakdown →
20131503
2
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
Hit paper breakdown →
20091002
3
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Hit paper breakdown →
2010570
4
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Hit paper breakdown →
2020414
5 2013251
6 2017187
7 2016166
8 201597
9 201771
10 200970
11 201653
12 201235
13 200834
14 201334
15 201629
16 201022
17 201222
18 201320
19 200317
20 201317

About Mitchell N. Davis

Mitchell N. Davis is a scholar working on Hepatology, Epidemiology, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 35 papers that have together received 4.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (34 papers) and Liver Disease Diagnosis and Treatment (1 paper). The work is most often cited by research in Hepatology (4k citations), Epidemiology (425 citations), Family Practice (11 citations), Biological Psychiatry (5 citations) and Infectious Diseases (67 citations). Mitchell N. Davis has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Eric Lawitz, Eugene R. Schiff, Jonathan McCone, Joseph Galati, Kenneth J. Koury, Lisa D. Pedicone, Clifford A. Brass, Janice K. Albrecht, John G. McHutchison and Mark Sulkowski. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Hepatology, The Lancet and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact